Tomotaka Nakayama

1.1k total citations
27 papers, 579 citations indexed

About

Tomotaka Nakayama is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Tomotaka Nakayama has authored 27 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Genetics. Recurrent topics in Tomotaka Nakayama's work include Pulmonary Hypertension Research and Treatments (21 papers), Cardiovascular Issues in Pregnancy (7 papers) and Vascular Anomalies and Treatments (6 papers). Tomotaka Nakayama is often cited by papers focused on Pulmonary Hypertension Research and Treatments (21 papers), Cardiovascular Issues in Pregnancy (7 papers) and Vascular Anomalies and Treatments (6 papers). Tomotaka Nakayama collaborates with scholars based in Japan, United States and United Kingdom. Tomotaka Nakayama's co-authors include Tsutomu Saji, Hiroyuki Matsuura, Shinichi Takatsuki, Toshio Nakanishi, Yoshiyuki Furutani, Kei Inai, Shigeaki Nonoyama, Masaki Shintani, Ayako Nagai and Yasushi Kemmotsu and has published in prestigious journals such as Circulation, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Tomotaka Nakayama

25 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomotaka Nakayama Japan 14 407 229 138 109 73 27 579
Cuizhen Pan China 14 123 0.3× 533 2.3× 120 0.9× 162 1.5× 52 0.7× 85 695
Mitsuya Murase Japan 15 289 0.7× 320 1.4× 68 0.5× 178 1.6× 5 0.1× 30 662
L.A. Bockeriа Russia 14 183 0.4× 346 1.5× 174 1.3× 290 2.7× 62 0.8× 142 674
Lori Claussen United States 9 713 1.8× 473 2.1× 182 1.3× 154 1.4× 112 1.5× 12 1.0k
Una Ørvim Norway 9 184 0.5× 322 1.4× 34 0.2× 216 2.0× 19 0.3× 10 684
Daryl G. Schulz United States 12 125 0.3× 361 1.6× 49 0.4× 348 3.2× 11 0.2× 27 653
Janine M. Wilkinson United Kingdom 10 313 0.8× 99 0.4× 182 1.3× 165 1.5× 66 0.9× 13 664
Ichiro Itagaki Japan 9 252 0.6× 302 1.3× 51 0.4× 209 1.9× 40 0.5× 16 917
Patrick W. Domkowski United States 10 118 0.3× 199 0.9× 56 0.4× 247 2.3× 8 0.1× 22 431
Shinya Fukui Japan 11 147 0.4× 190 0.8× 76 0.6× 173 1.6× 13 0.2× 56 368

Countries citing papers authored by Tomotaka Nakayama

Since Specialization
Citations

This map shows the geographic impact of Tomotaka Nakayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomotaka Nakayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomotaka Nakayama more than expected).

Fields of papers citing papers by Tomotaka Nakayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomotaka Nakayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomotaka Nakayama. The network helps show where Tomotaka Nakayama may publish in the future.

Co-authorship network of co-authors of Tomotaka Nakayama

This figure shows the co-authorship network connecting the top 25 collaborators of Tomotaka Nakayama. A scholar is included among the top collaborators of Tomotaka Nakayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomotaka Nakayama. Tomotaka Nakayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takatsuki, Shinichi, et al.. (2022). Clinical efficacy and safety of selexipag in children and young adults with idiopathic and heritable pulmonary arterial hypertension. Cardiology in the Young. 33(2). 196–200. 8 indexed citations
2.
Miyamoto, Kenji, Kei Inai, Tohru Kobayashi, et al.. (2021). Outcomes of idiopathic pulmonary arterial hypertension in Japanese children: a retrospective cohort study. Heart and Vessels. 36(9). 1392–1399. 5 indexed citations
3.
Shimizu, Jun, et al.. (2019). Friction characteristics of mechanically microtextured metal surface in dry sliding. Tribology International. 149. 105634–105634. 59 indexed citations
4.
Nagai, Ayako, Masaki Shintani, Hiroki Sato, et al.. (2019). Role of BRCA1-associated protein (BRAP) variant in childhood pulmonary arterial hypertension. PLoS ONE. 14(1). e0211450–e0211450. 2 indexed citations
5.
Sawada, Hirofumi, Yoshihide Mitani, Tomotaka Nakayama, et al.. (2018). Detection of Pediatric Pulmonary Arterial Hypertension by School Electrocardiography Mass Screening. American Journal of Respiratory and Critical Care Medicine. 199(11). 1397–1406. 22 indexed citations
6.
Takatsuki, Shinichi, et al.. (2018). Clinical Effects of Syncope on Disease Severity and Adverse Outcomes in Children with Idiopathic and Heritable Pulmonary Arterial Hypertension. Pediatric Cardiology. 40(1). 209–214. 10 indexed citations
7.
Takatsuki, Shinichi, et al.. (2016). Pulmonary Arterial Capacitance Index Is a Strong Predictor for Adverse Outcome in Children with Idiopathic and Heritable Pulmonary Arterial Hypertension. The Journal of Pediatrics. 180. 75–79.e2. 21 indexed citations
8.
Mori, Hiroki, Hiroyuki Yamagishi, Makoto Nakamura, et al.. (2016). Sildenafil reduces pulmonary vascular resistance in single ventricular physiology. International Journal of Cardiology. 221. 122–127. 33 indexed citations
9.
Nagai, Ayako, Hiroki Sato, Masaki Shintani, et al.. (2013). Soluble ST2 and N-terminal pro-Brain Natriuretic Peptide Combination. Circulation Journal. 78(2). 436–442. 34 indexed citations
10.
Hara, Hidehiko, Tomotaka Nakayama, Hiroyuki Matsuura, et al.. (2012). Transcatheter atrial septal defect closure in a patient with paradoxical brain emboli: who should treat it and who should be treated?. Cardiovascular Intervention and Therapeutics. 27(3). 214–217. 1 indexed citations
11.
Takatsuki, Shinichi, Tomotaka Nakayama, Pei‐Ni Jone, et al.. (2012). Tissue Doppler Imaging Predicts Adverse Outcome in Children with Idiopathic Pulmonary Arterial Hypertension. The Journal of Pediatrics. 161(6). 1126–1131.e2. 41 indexed citations
12.
Nagai, Ayako, Masaki Shintani, Tomotaka Nakayama, et al.. (2012). Missense Mutations of the <i>BMPR1B</i> (<i>ALK6</i>) Gene in Childhood Idiopathic Pulmonary Arterial Hypertension. Circulation Journal. 76(7). 1804–1804. 3 indexed citations
13.
Nagai, Ayako, Masaki Shintani, Tomotaka Nakayama, et al.. (2012). Missense Mutations of the <i>BMPR1B</i> (<i>ALK6</i>) Gene in Childhood Idiopathic Pulmonary Arterial Hypertension. Circulation Journal. 76(6). 1501–1508. 64 indexed citations
14.
Kemmotsu, Yasushi, Tomotaka Nakayama, Hiroyuki Matsuura, & Tsutomu Saji. (2011). Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease. Pediatric Rheumatology. 9(1). 28–28. 38 indexed citations
15.
Taguchi, Masato, Fukiko Ichida, Keiichi Hirono, et al.. (2011). Pharmacokinetics of Bosentan in Routinely Treated Japanese Pediatric Patients with Pulmonary Arterial Hypertension. Drug Metabolism and Pharmacokinetics. 26(3). 280–287. 25 indexed citations
16.
Satoh, Mari, et al.. (2010). Autoimmune Thyroid Disease in Children and Adolescents With Idiopathic Pulmonary Arterial Hypertension. Circulation Journal. 74(2). 371–374. 15 indexed citations
17.
Takatsuki, Shinichi, Yuka Ito, Daiji Takeuchi, et al.. (2009). IVIG Reduced Vascular Oxidative Stress in Patients With Kawasaki Disease. Circulation Journal. 73(7). 1315–1318. 31 indexed citations
18.
Saji, Tsutomu, Tomotaka Nakayama, & Hiroyuki Matsuura. (2008). [Pulmonary arterial hypertension in pediatric age].. PubMed. 66(11). 2193–9. 2 indexed citations
19.
20.
Nakayama, Tomotaka, et al.. (2003). The Imbalance between Matrix Metalloproteinase-9, -2 and Tissue Inhibitor of Metalloproteinases-1 in Acute Phase Kawasaki Disease. Pediatric Research. 53(1). 170–170. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cuizhen Pan Breakdown of academic impact, for papers by Mitsuya Murase Breakdown of academic impact, for papers by L.A. Bockeriа Breakdown of academic impact, for papers by Lori Claussen Breakdown of academic impact, for papers by Una Ørvim Breakdown of academic impact, for papers by Daryl G. Schulz Breakdown of academic impact, for papers by Janine M. Wilkinson Breakdown of academic impact, for papers by Ichiro Itagaki Breakdown of academic impact, for papers by Patrick W. Domkowski Breakdown of academic impact, for papers by Shinya Fukui
Rankless by CCL
2026